162 related articles for article (PubMed ID: 19941161)
1. Combined genetic effect of CDK7 and ESR1 polymorphisms on breast cancer.
Jeon S; Choi JY; Lee KM; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
Breast Cancer Res Treat; 2010 Jun; 121(3):737-42. PubMed ID: 19941161
[TBL] [Abstract][Full Text] [Related]
2. Association Between ESR1 PvuII, XbaI, and P325P Polymorphisms and Breast Cancer Susceptibility: A Meta-Analysis.
Zhang Y; Zhang M; Yuan X; Zhang Z; Zhang P; Chao H; Jiang L; Jiang J
Med Sci Monit; 2015 Oct; 21():2986-96. PubMed ID: 26434778
[TBL] [Abstract][Full Text] [Related]
3. Impact of ESR1 Polymorphisms on Risk of Breast Cancer in the Chinese Han Population.
Yang W; He X; He C; Peng L; Xing S; Li D; Wang L; Jin T; Yuan D
Clin Breast Cancer; 2021 Jun; 21(3):e235-e242. PubMed ID: 33281037
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of ESR1 rs2881766 increases breast cancer risk in Korean women.
Son BH; Kim MK; Yun YM; Kim HJ; Yu JH; Ko BS; Kim H; Ahn SH
J Cancer Res Clin Oncol; 2015 Apr; 141(4):633-45. PubMed ID: 25323936
[TBL] [Abstract][Full Text] [Related]
5. Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis.
Li N; Dong J; Hu Z; Shen H; Dai M
Breast Cancer Res Treat; 2010 May; 121(1):177-84. PubMed ID: 19760036
[TBL] [Abstract][Full Text] [Related]
6. A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
Li T; Zhao J; Yang J; Ma X; Dai Q; Huang H; Wang L; Liu P
PLoS One; 2016; 11(4):e0153314. PubMed ID: 27070141
[TBL] [Abstract][Full Text] [Related]
7. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.
Zhang L; Gu L; Qian B; Hao X; Zhang W; Wei Q; Chen K
Breast Cancer Res Treat; 2009 Mar; 114(2):327-38. PubMed ID: 18629629
[TBL] [Abstract][Full Text] [Related]
8. Menopausal status modifies breast cancer risk associated with ESR1 PvuII and XbaI polymorphisms in Asian women: a HuGE review and meta-analysis.
Li LW; Xu L
Asian Pac J Cancer Prev; 2012; 13(10):5105-11. PubMed ID: 23244119
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of functional genetic variants at 6q25.1 and risk of breast cancer in a Chinese population.
Wang Y; He Y; Qin Z; Jiang Y; Jin G; Ma H; Dai J; Chen J; Hu Z; Guan X; Shen H
Breast Cancer Res; 2014 Aug; 16(4):422. PubMed ID: 25116933
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women.
Choi JY; Shin A; Park SK; Chung HW; Cho SI; Shin CS; Kim H; Lee KM; Lee KH; Kang C; Cho DY; Kang D
Calcif Tissue Int; 2005 Sep; 77(3):152-9. PubMed ID: 16151677
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer.
Chae YK; Huang HY; Strickland P; Hoffman SC; Helzlsouer K
PLoS One; 2009 Aug; 4(8):e6523. PubMed ID: 19654868
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of CAK genes and risk for lung cancer: a case-control study in Chinese population.
Li Y; Jin G; Wang H; Liu H; Qian J; Gu S; Ma H; Miao R; Hu Z; Sun W; Wang Y; Jin L; Wei Q; Shen H; Huang W; Lu D
Lung Cancer; 2007 Nov; 58(2):171-83. PubMed ID: 17707548
[TBL] [Abstract][Full Text] [Related]
13. Diverse associations between ESR1 polymorphism and breast cancer development and progression.
Ding SL; Yu JC; Chen ST; Hsu GC; Hsu HM; Ho JY; Lin YH; Chang CC; Fann CS; Cheng CW; Wu PE; Shen CY
Clin Cancer Res; 2010 Jul; 16(13):3473-84. PubMed ID: 20570923
[TBL] [Abstract][Full Text] [Related]
14. Association Between ESR1 XBAI and Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis.
Sun T; Lian R; Liang X; Sun D
Clin Invest Med; 2022 Mar; 45(1):E21-34. PubMed ID: 35339126
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in ESR1 and FLJ43663 are associated with breast cancer risk in the Han population.
Xia P; Jin T; Geng T; Sun T; Li X; Dang C; Kang L; Chen C; Sun J
Tumour Biol; 2014 Mar; 35(3):2187-90. PubMed ID: 24127041
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.
Li Y; Li Y; Wedrén S; Li G; Charn TH; Desai KV; Bonnard C; Czene K; Humphreys K; Darabi H; Einarsdóttir K; Heikkinen T; Aittomäki K; Blomqvist C; Chia KS; Nevanlinna H; Hall P; Liu ET; Liu J
Breast Cancer Res; 2011 Jan; 13(1):R10. PubMed ID: 21269472
[TBL] [Abstract][Full Text] [Related]
17. The Decisive Case-Control Study Elaborates the Null Association between
Huang YH; Fang WH; Tsai DJ; Chen YH; Wang YC; Su W; Kao CC; Yi K; Wang CC; Su SL
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33808990
[TBL] [Abstract][Full Text] [Related]
18. The association between a novel polymorphism (rs1062577) in ESR1 and breast cancer susceptibility in the Han Chinese women.
Chen L; Kang H; Jin GJ; Chen X; Zhang QY; Lao WT; Li R
Gynecol Endocrinol; 2016 Jul; 32(7):553-6. PubMed ID: 26850117
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor alpha (ESR1) gene polymorphism (rs2234693 and rs2046210) with breast cancer risk in pashtun population of Khyber Pakhtunkhwa.
Shahzad S; Khan NU; Sombal W; Shah RU; Khan AU; Iqbal A; Munir I
Mol Biol Rep; 2023 Mar; 50(3):2445-2451. PubMed ID: 36595122
[TBL] [Abstract][Full Text] [Related]
20. Selected estrogen receptor 1 and androgen receptor gene polymorphisms in relation to risk of breast cancer and fibrocystic breast conditions among Chinese women.
Sakoda LC; Blackston CR; Doherty JA; Ray RM; Lin MG; Gao DL; Stalsberg H; Feng Z; Thomas DB; Chen C
Cancer Epidemiol; 2011 Feb; 35(1):48-55. PubMed ID: 20846920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
